Glycosylated haemoglobin: measurement and clinical use.
نویسنده
چکیده
The discovery, biochemistry, laboratory determination, and clinical application of glycosylated haemoglobins are reviewed. Sources of error are discussed in detail. No single assay method is suitable for all purposes, and in the foreseeable future generally acceptable standards and reference ranges are unlikely to be agreed. Each laboratory must establish its own. Nevertheless, the development of glycosylated haemoglobin assays is an important advance. They offer the best available means of assessing diabetic control.
منابع مشابه
Hereditary spherocytosis, a pitfall in the assessment of glycaemic control.
The use of glycosylated haemoglobin in the assessment of diabetic control is ubiquitous. Hereditary spherocytosis is a haemolytic anaemia with shortened red blood cell lifespan, which can interfere with the methods of glycosylated haemoglobin measurement. We report a case of hereditary spherocytosis in a young man with type 1 diabetes, and illustrate the discrepancy in the measurements of glyco...
متن کاملهموگلوبین گلیکوزیله در بیماران مبتلا به پرفشاری خون اولیه
Introduction: In this study, we compared the level of glycosylated haemoglobin in patients with essential hypertension and healthy controls.Method: 70 non-diabetic patients with essential hypertension were recruited into the study along with 140 controls without any significant medical history. Persons with a history of metabolic disease, anaemia, renal disease, splenectomy, pregnancy, or on me...
متن کاملGlycosylated haemoglobin in dogs: study of critical difference value.
Measurement of glycated proteins can be of use in diagnosis and monitoring of diabetic dogs. Its use in monitoring can be facilitated by comparison of results with a reference interval derived from levels in normal dogs. In this study, a commercial immunoturbidometric assay was used to measure glycosylated haemoglobin in 15 normal dogs over a 5-week period. Following statistical analysis of the...
متن کاملCentralised versus local measurement of glycated haemoglobin in clinical trial settings: a comment on Arch et al., Trials. 2016
Arch and colleagues in their 24 October 2016 paper in Trials focus on the issue of centralised versus local measurement of glycated haemoglobin (HbA1c) in clinical trial settings. Resolution of the debate is important: while local HbA1c measurement is less costly, and would thereby ease the stretched funding situations for clinical trials worldwide, it cannot be implemented at the expense of cl...
متن کاملClinical applications of glycosylated haemoglobin
Glycosylated haemoglobin (HbA1c) has been in use since 1980s as the 'gold standard' for monitoring glycaemic control and as a predictor of diabetic complications. Even though several conditions, such as, haemolytic anaemia (lowers HbA1c) and aplastic anaemia (raises HbA1c) tend to confound and interfere with HbA1c measurement, in most circumstances HbA1c is a valid and reliable index of glycaem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of clinical pathology
دوره 37 8 شماره
صفحات -
تاریخ انتشار 1984